In 2023, hospital discharges for dermatitis, eczema, and papulosquamous disorders in the UK stood at an estimated 6,530. The forecast indicates a consistent downward trend from 2024 through to 2028, with discharges decreasing by approximately 5% year-on-year. Over this period, the Compound Annual Growth Rate (CAGR) is expected to be negative, reflecting an average annual decline of around 5.8% due to improved management and preventive care.

Future trends to watch for include:

Potential impact of advancements in dermatological treatments reducing hospitalization needs.
Increasing focus on preventive measures and outpatient management.
Potential policy changes in healthcare affecting hospital admissions and treatment of chronic skin conditions.